Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
Clear All Simple Search
Advanced Search
TB drug resistance in the U.S.
  • Published Date:
    November 2013
  • Source:
    CDC fact sheet
  • Language:
Filetype[PDF-218.03 KB]

  • Description:
    Causes of TB drug resistance -- Multidrug-resistant TB (MDR TB) -- Extensively drug-resistant TB (XDR TB) -- TB drug shortages -- Preventing drug-resistant TB.

    Tuberculosis (TB) is a serious respiratory disease caused by bacteria that are spread from person to person through the air. In most cases, TB is treatable and curable; however, TB can be deadly without proper treatment. TB bacteria can become resistant to the drugs used for treatment. When this occurs, treatment is often still possible, but it is complex, long, challenging, and expensive. Rates of drug-resistant TB remain relatively low in the United States, though nearly half a million cases are estimated to occur globally each year.1 These cases underscore the need for ongoing vigilance and action, especially given the ease with which TB can spread through international travel and migration. The Centers for Disease Control and Prevention works with state and local health departments and other health care providers to prevent the spread of TB, track drug-resistant cases, assist with diagnosis as needed, and help ensure that patients with drug-resistant TB receive effective treatment and care.

  • Place as Subject:
  • Main Document Checksum:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: